AstraZeneca PLC
Symbol: AZN (NASDAQ)
82.13
▲ (0.42%) 0.345
Company Description:
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
Key Stats
- Today's Open: $82.05
- Today's High: $82.55
- Today's Low: $81.528
- Today's Volume: 2.46M
- Yesterday Close: $81.78
- Yesterday High: $82.28
- Yesterday Low: $81.48
- Yesterday Volume: 3.12M
- Last Min Volume: 76
- Last Min High: $82.125
- Last Min Low: $82.125
- Last Min VWAP: $82.125
Company Profile
- Name: AstraZeneca PLC
- Website: https://www.astrazeneca.com
- Listed Date: 1993-05-18
- Location: ,
- Market Status: Active
- CIK Number: 0000901832
- SIC Code:
- SIC description:
- Market Cap: $253.31B
- Round Lot: 100
- Outstanding Shares: 3.10B
- Asset Type: ADRC
RECENT FILINGS FOR AZN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-02 | 6-K | View |
| 2025-08-28 | 6-K | View |
| 2025-08-26 | 6-K | View |
| 2025-08-21 | 6-K | View |
| 2025-08-18 | 6-K | View |
| 2025-08-15 | 6-K | View |
| 2025-08-12 | 6-K | View |
| 2025-08-01 | 6-K | View |
| 2025-07-29 | 6-K | View |
| 2025-07-24 | 6-K | View |
| 2025-07-22 | 6-K | View |
| 2025-07-16 | 6-K | View |
| 2025-07-14 | 6-K | View |
| 2025-07-07 | 6-K | View |
| 2025-07-01 | 6-K | View |
| 2025-06-26 | 11-K | View |
| 2025-06-24 | 6-K | View |
| 2025-06-13 | 6-K | View |
| 2025-06-12 | 6-K | View |
| 2025-06-06 | 6-K | View |
Latest News on AZN